| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-19 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-18 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-17 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-16 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-15 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-15 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-15 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-14 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-14 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-14 |